Melissa Langer
About Melissa Langer
Melissa Langer is a Scientist III with extensive experience in molecular detection and product development. She has worked at various institutions, including Advanced Animal Diagnostics and Baebies, contributing to significant advancements in diagnostic technologies.
Current Role at Baebies
Melissa Langer has been employed at Baebies as a Scientist III since 2018. In her current role, she focuses on the development of diagnostic tools and methodologies. Her work includes contributions to the molecular detection of various viruses, including SARS-CoV-2 and Cytomegalovirus. Langer's expertise in this area supports Baebies' mission to improve newborn screening and diagnostics.
Previous Experience at Advanced Animal Diagnostics
Prior to her role at Baebies, Melissa Langer worked as a Product Development Scientist at Advanced Animal Diagnostics from 2014 to 2017. During her tenure, she developed diagnostic panels for lysosomal storage disorders, acute kidney injury, and blood clotting diseases. This experience contributed to her understanding of veterinary diagnostics and product development.
Educational Background in Biological Sciences
Melissa Langer studied at California State Polytechnic University, Pomona, where she earned a Bachelor of Science degree in Microbiology from 2010 to 2014. She also attended the Collins College of Hospitality Management at Cal Poly Pomona. Her educational background provided a strong foundation in biological sciences, which she has applied throughout her career.
Research Experience and Technical Skills
Langer has completed research internships at the University of Oxford, enhancing her research skills and technical knowledge. She possesses expertise in robotic liquid handling and has developed a patented lateral flow device for detecting mastitis in dairy and beef cattle. Additionally, she has experience in developing techniques for assessing small molecule therapeutic quality during purification processes.
Patent and Innovation Contributions
Melissa Langer has made significant contributions to innovation in her field. She holds a patent-pending detection method for mucopolysaccharidosis and has developed various diagnostic tools. Her work reflects a commitment to advancing diagnostic methodologies and improving health outcomes.